Physician profile
Mark Ray Pearson
NPI 1609114073
$2,673.26
in general payments reported to CMS, 2019-2025
19 companies · $202 in 2025
The $202 reported for 2025 was more than what 83% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $391 · 2020: $206 · 2021: $161 · 2022: $88.07 · 2023: $1,623 · 2024: $2.22 · 2025: $202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,600 · Food and Beverage: $228.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,600.00 |
| Food and Beverage | $227.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,600.00 | 2023 | Cardiomems |
| Solventum Corporation | $168.17 | 2025 | Prevena, 3m Coban |
| Misonix INC | $116.82 | 2019 | |
| Smith+Nephew, INC. | $114.84 | 2019-2025 | Renasys Touch, Grafix Pl |
| Abiomed | $111.14 | 2020 | |
| Stryker Corporation | $104.96 | 2019 | |
| Integra Lifesciences Corporation | $75.78 | 2020 | |
| Organogenesis INC. | $67.99 | 2019-2021 | |
| Kci USA, INC. | $52.42 | 2021-2022 | |
| Tei Medical INC. | $49.17 | 2019 | |
| Convatec INC. | $38.69 | 2021-2022 | |
| Polynovo North America LLC | $36.52 | 2019 | |
| Tactile Systems Technology INC | $28.03 | 2021 | |
| Osiris Therapeutics INC. | $22.54 | 2019 | |
| Kerecis Limited | $20.49 | 2021-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Next Science LLC | $19.47 | 2023 | Blastx, Xperience, Surgx |
| Hartmann USA, INC. | $19.08 | 2022 | |
| Medline Industries Lp | $13.83 | 2019 | |
| Aroa Biosurgery Incorporated | $13.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Pearson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.